A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicentre Phase ◽

Colorectal Cancer Patients ◽

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6603493 ◽

2007 ◽

Vol 96 (3) ◽

pp. 439-444 ◽

Cited By ~ 21

Author(s):

E Bajetta ◽

◽

M Di Bartolomeo ◽

R Buzzoni ◽

L Mariani ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Colorectal Cancer Patients ◽

Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2014.12.020 ◽

2015 ◽

Vol 51 (4) ◽

pp. 473-481 ◽

Cited By ~ 10

Author(s):

Maria Di Bartolomeo ◽

Andrea Ciarlo ◽

Alessandro Bertolini ◽

Sandro Barni ◽

Claudio Verusio ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Medical Oncology ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Bevacizumab + folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (prot. GOIM 2601)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15048 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15048-15048

Author(s):

G. Colucci ◽

F. Giuliani ◽

V. Lorusso ◽

F. De Vita ◽

S. Cinieri ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

P9 Comparison of cetuximab and bevacizumab as first-line treatment in KRAS wild type advanced colorectal cancer patients: a retrospective analysis

European Journal of Cancer ◽

10.1016/s0959-8049(14)70040-1 ◽

2014 ◽

Vol 50 ◽

pp. S12

Author(s):

Q. Zhang ◽

R. Leung ◽

H. Wong ◽

J. Chiu ◽

K.W. Chu ◽

...

Keyword(s):

Colorectal Cancer ◽

Retrospective Analysis ◽

Cancer Patients ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

Colorectal Cancer Patients ◽

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC-03-2018)

BMC Cancer ◽

10.1186/s12885-020-07268-4 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Angela Damato ◽

Francesco Iachetta ◽

Lorenzo Antonuzzo ◽

Guglielmo Nasti ◽

Francesca Bergamo ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Phase II Study Alternating Mfolfox 6 and Folfiri (FIREFOX) Plus Bevacizumab (BEV) Regimen in First-Line Treatment of Advanced Colorectal Cancer in Japanese Patients (KSCC 0801)

Annals of Oncology ◽

10.1016/s0923-7534(20)32375-9 ◽

2012 ◽

Vol 23 ◽

pp. xi130

Author(s):

Y. Emi ◽

Y. Ogata ◽

Y. Akagi ◽

Y. Kakeji ◽

E. Oki ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Line Treatment ◽

First Line ◽

Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC) –A phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3712 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3712-3712 ◽

Cited By ~ 1

Author(s):

D. Tsavdaridis ◽

A. Athanasiadis ◽

N. Pissanidis ◽

M. Saleh ◽

A. Moshidis ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study

Oncology ◽

10.1159/000055350 ◽

2001 ◽

Vol 61 (1) ◽

pp. 36-41 ◽

Cited By ~ 9

Author(s):

Ch. Kouroussis ◽

J. Souglakos ◽

S. Kakolyris ◽

D. Mavroudis ◽

N. Malamos ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study

Annals of Oncology ◽

10.1093/annonc/mdi193 ◽

2005 ◽

Vol 16 (6) ◽

pp. 869-877 ◽

Cited By ~ 46

Author(s):

H.P. Kalofonos ◽

G. Aravantinos ◽

P. Kosmidis ◽

P. Papakostas ◽

T. Economopoulos ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer

Annals of Oncology ◽

10.1093/annonc/mdg360 ◽

2003 ◽

Vol 14 (9) ◽

pp. 1378-1382 ◽

Cited By ~ 45

Author(s):

M. Zeuli ◽

C. Nardoni ◽

M.S. Pino ◽

T. Gamucci ◽

A. Gabriele ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽